Ad Rem Technology is a French Med Tech, specialized in the design and development of innovative medical devices. Its technology is based on the principle of electrostimulation applied to vascular pathologies. The technology developed by an American scientist, Doctor Jozef Cywinski, who specializes in the development of neuromuscular stimulators. Inventor of pacemakers as well as therapeutic and diagnostic pacemakers, he has conducted extensive research and taught at Harvard "University Medical School" (Boston, MA, USA), Massachusetts General Hospital, and the Massachusetts Institute of Technology (Cambridge, MA, USA). He was elected "Senior Member of the Institute of Electronic & Electrical Engineers" (IEEE) and "Fellow of the American College of Cardiology" (FACC). VEINOPLUS® is a new treatment for vascular pathologies: from heavy legs to Chronic Venous Insufficiency. It is a medical device that has therapeutic effects on various symptoms of Venous Insufficiency. These effects have been demonstrated and documented in several clinical studies carried out since 2004 in France, the United Kingdom, Russia and the USA. Early 2013 launch of a device for the treatment of obliterating arteriopathy of the lower limbs as well as a device for the mechanical prevention of DVT. Veinoplus Sport, a device to improve the recovery and performance of athletes was launched on the occasion of the London 2012 Olympic Games. This device has been the subject of clinical studies published with the INSEP research center. Veinoplus is a range of class IIa medical devices, medical CE 2797 & FDA 510k (USA) certified. China FDA certification was obtained in 2021. We have published more than 25 clinical studies to date Ad Rem Technology is ISO 13485:2016 certified Thierry TAVIDIAN, Founder and CEO of Ad Rem Technology, is a winner of Paris-Entreprendre